The effect of Tribulus terrestris on Immune Thrombocytopenic Purpura
Phase 3
- Conditions
- Immune Thrombocytopenic Purpura.Idiopathic thrombocytopenic purpura
- Registration Number
- IRCT2015062322884N1
- Lead Sponsor
- Vice Chancellor for research of Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Non-medication with any drugs such as corticosteroids
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Counts of platelets. Timepoint: Before intervention, one day, two weeks and four weeks after intervention. Method of measurement: Count of platelets and blood cells using cell counter device and report as cells/microliter of blood.;Platelet factor 4 (PF4) level. Timepoint: Before intervention, one day, two weeks and four weeks after intervention. Method of measurement: Assay of PF4 using ELISA method and report at ng/ml of serum.;Von Willebrand factor level. Timepoint: Before intervention, one day, two weeks and four weeks after intervention. Method of measurement: Assay using ELISA and report at ng/ml of serum.;Serotonin level. Timepoint: Before intervention, one day, two weeks and four weeks after intervention. Method of measurement: Assay using ELISA and report at ng/ml of serum.
- Secondary Outcome Measures
Name Time Method Purpura (Skin hemorrhagic spots). Timepoint: Before intervention, one day, two weeks and four weeks after intervention. Method of measurement: Distribution of spots by visual examination and size of spots by a ruler (mm).